Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), a key antibacterial protein, is highly elevated in patients with end-stage liver disease that is often associated with bacterial infection. LCN2 is expressed at high levels in both hepatocytes and neutrophils; however, how hepatocyte-derived and neutrophil-derived LCN2 cooperate to combat bacterial infection remains unclear. Here, by studying hepatocyte-specific and myeloid-specific Lcn2 knockout mice in two models of systemic and local Klebsiella pneumoniae infections, we demonstrated that hepatocytes played a critical role in controlling systemic infection by secreting LCN2 protein into the circulation following intraperitoneal injection of bacteria, whereas neutrophils were more important in combating local lung infection by carrying LCN2 in their specific granules to the local infection site following intratracheal intubation of bacteria. Both hepatocyte-derived and myeloid cell-derived LCN2 were required against bacterial infection in the peritoneal cavity and liver necrotic areas following intraperitoneal injection of Klebsiella pneumoniae. LCN2/NGAL protein was detected in neutrophil extracellular traps (NETs) in activated neutrophils from mice and humans. Disruption of the Lcn2 gene in neutrophils abolished LCN2 on NETs, whereas deletion of this gene in hepatocytes did not affect LCN2 protein on NETs. Genetic deletion of the Lcn2 gene globally or specifically in neutrophils did not affect NET formation but reduced the bactericidal effect of NETs in vitro. Finally, NGAL-positive NETs were detected in the liver from patients with various types of liver diseases. Conclusion: Both hepatocytes and neutrophils combat bacterial infection through the production of LCN2; extracellular LCN2 secreted by hepatocytes limits systemic bacterial infection, whereas neutrophils carry LCN2 protein to the local site and against local bacterial infection through NETs. (HEPATOLOGY 2018; 68:1604-1620.
L ipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL; human ortholog of the mouse Lcn2 gene), is one of the most extensively investigated acute-phase proteins because its levels are highly elevated (up to 6 lg/mL in the serum (1) ) under all inflammatory conditions (2) including in liver disease. (3) It is well documented that LCN2 plays a critical role in host defense against bacterial infection by sequestering iron-containing siderophores. (4) Siderophores are among the strongest soluble Fe 31 binding agents known, and bacteria obtain iron by producing siderophores. LCN2 can bind to and subsequently sequester iron-containing siderophores, thereby preventing uptake of iron by bacteria and limiting their growth. (4) In contrast to its well-established bacteriostatic function, the other functions of LCN2 are less clear; and reports regarding this area are controversial. For example, the experimental data suggest that LCN2 promotes liver injury and inflammation in alcoholic steatohepatitis (5, 6) and nonalcoholic steatohepatitis (NASH), (7) but other studies suggest that LCN2 protects against acute liver injury induced by hepatotoxins (8) and promotes liver regeneration. (1) Clinical studies have revealed that serum NGAL levels are markedly elevated in various types of liver diseases, and NGAL is a predictor for mortality and bacterial infection in patients with liver cirrhosis, (9) (10) (11) (12) suggesting that LCN2/NGAL is associated with bacterial infection in liver cirrhosis. It is well known that both hepatocytes and neutrophils are important cell types that produce LCN2/NGAL and combat bacterial infection (1, 13) ; however, how these two types of cells cooperate to combat bacterial infection through the production of LCN2/NGAL remains unclear.
The liver is a critical innate immunity organ in the body against invading microorganisms by secreting a large number of innate immunity proteins including LCN2/NGAL into the blood. (14) LCN2 is highly elevated in the serum in mice post-bacterial infection (from 60 ng/mL at basal levels to 6 lg/mL postinfection).
(1) Such highly elevated circulating LCN2 levels are mainly secreted by hepatocytes (1) and play a critical role in inhibiting bacterial infection by sequestrating iron-chelating siderophores. (4) Interestingly, neutrophils also express high levels of LCN2, which are usually stored in their specific granules. (13) Both the extracellular LCN2 produced by hepatocytes and the intracellular LCN2 stored in the granules of neutrophils likely play important roles in host defense against bacterial infection (15) ; however, how these two forms of LCN2 interact and combat bacterial infection is not fully understood.
Neutrophils are the most abundant innate immune cells in the human body. To control bacterial infection, neutrophils migrate from peripheral blood to infected tissues and perform their functions against bacterial infection through three strategies: phagocytosis, degranulation, and the formation of neutrophil extracellular traps (NETs). Formation of NETs is a recently identified mechanism to kill bacteria by neutrophils through both cell death-dependent and cell deathindependent pathways. (16, 17) The death pathway termed "NETosis" is associated with nuclear delobulation, loss of cellular polarization, chromatin decondensation, and plasma membrane rupture. (16, 17) The cell death-independent pathway is mediated by expelling nuclear chromatin and releasing granule proteins through degranulation. (16, 17) Conversion of histone arginines to citrullines by peptidyl arginine deiminase 4 is a critical step of NET formation following specific types of stimulation, which reduces the strong positive charge of histones, weakens histone-DNA binding, and subsequently unwraps the nucleosomes. (18) Proteomic analyses of NET protein composition have detected up to 80 proteins in NETs including several granule proteins: neutrophil elastase, myeloperoxidase (MPO), defensins, NGAL, etc. (19) (20) (21) The granule protein LCN2/NGAL was also identified in zymographic analyses of purified NETs in which a 125-kDa high-molecular weight gelatinase, a complex of matrix metalloproteinase-9 and NGAL, (22) was detected. (23) However, the role of LCN2 in NET formation and function has not been systematically investigated.
Our previous study showed that hepatocyte-derived LCN2 is secreted to circulating blood to inhibit bacterial infection.
(1) Given that LCN2 is also stored in the specific granules of neutrophils, the role of intracellular LCN2 is not clear. Thus, we generated myeloidspecific Lcn2 knockout (KO) (Lcn2
) mice with hepatocyte-specific Lcn2 KO (Lcn2
) and double KO (Lcn2 DKO ) mice, subjecting them to lipopolysaccharide (LPS) injection and Klebsiella pneumoniae (K. pneumoniae) infection models. Using these mice, we demonstrate that both hepatocytes and myeloid cells combat bacterial infection through the production of LCN2. Extracellular LCN2 protein secreted by hepatocytes plays a critical role in limiting systemic bacterial infection, whereas intracellular LCN2 protein from neutrophils is a component of NETs, playing a critical role in suppressing local bacterial infection through NETs.
Materials and Methods

ANIMALS
Lcn2
flox/flox (Lcn2 f/f ) mice have been described.
(1)
Hep2/2 and Lcn2 Mye2/2 were generated by a few steps including crossing Lcn2 f/f mice with Albumin Cre mice and Lysosome Cre mice (Jackson Laboratory, Bar Harbor, ME), respectively. Lcn2 Hep2/2 mice were then crossed with Lcn2
Mye2/2 mice to obtain four lines of mice: Lcn2 ) on a C57BL/6N background have been described. (1) All mice were cared for in accordance with National Institutes of Health guidelines. All animal studies were approved by the National Institute on Alcohol Abuse and Alcoholism's Animal Care and Use Committee. CFU. For the lung bacterial infection model, mice were given K. pneumoniae strain 43816 (5 3 10 6 CFU) through a noninvasive intratracheal intubation as described. (24) All mice were sacrificed under anesthesia by inhalation of isoflurane. (25) All samples were collected by snap-freezing in liquid nitrogen.
ANIMAL MODELS
HUMAN LIVER SAMPLES
NET FORMATION AND QUANTIFICATION IN VITRO AND IN VIVO
NET quantification was to costain with a nuclear marker (e.g., DNA, citrulline-histone [cit-histone]) and a neutrophil granule marker (e.g., MPO, elastase, LCN2/NGAL). In the current study, several different combinations were used to quantify NETs. Histone citrullination specifically occurs during NET formation, (18) so we used costaining of cit-histone and a neutrophil marker for in vivo NET quantification. See details in Supporting Information.
STATISTICAL ANALYSIS
GraphPad Prism 7 (GraphPad Software, La Jolla, CA) was used to analyze data. To compare values obtained from three or more groups, a one-way analysis of variance was used, followed by Tukey's post hoc test. To compare values between two groups, an unpaired t test was used. Data are presented as means 6 SEM, with a significant difference at the level of P < 0.05.
Other methods are described in the Supporting Information.
Results
LPS INJECTION ELEVATES INTRACELLULAR LCN2 EXPRESSION IN NEUTROPHILS AND EXTRACELLULAR LCN2 SECRETION FROM HEPATOCYTES
LPS injection up-regulated LCN2 protein and Lcn2 mRNA expression in different mouse organs including liver, kidney, intestine, and spleen (Supporting Fig.  S1A ,B). Among them, the liver had the highest fold induction of Lcn2 mRNA post-LPS injection (Supporting Fig. S1B ), which was further investigated. Hepatic Lcn2 mRNA was markedly up-regulated more than 200-fold, with peak effect 6 hours after LPS injection (Fig. 1A) . But surprisingly, immunohistochemical analysis revealed that strong LCN2 protein staining was observed in nonparenchymal/immune cells but not in hepatocytes, with the strongest staining 6 hours postinjection ( Fig. 1B; Supporting Fig. S2A ). To further confirm whether strong LCN2 protein is expressed in neutrophils, we performed double staining of LCN2 and MPO. More than 80% of LCN2-positive staining overlapped with MPO staining in liver tissues from mice 6 hours post-LPS injection, suggesting that strong LCN2 protein is detected in intrahepatic neutrophils post-LPS injection ( Fig. 1C; Supporting Fig. S2B) . Interestingly, the number of LCN2 1 cells was markedly decreased, with only approximately 40% and 20% MPO 1 cells being LCN2-positive 12 and 24 hours post-LPS injection, which may be because LCN2 proteins were secreted through the granule release at later time points after neutrophil activation. Moreover, LCN2 protein was barely detected in the normal livers from mice without LPS treatment (control group) (Fig.  1B,C) . Finally, quantitative RT-PCR analyses demonstrated that Lcn2 mRNA levels were highly upregulated in the isolated intrahepatic neutrophils from LPS-treated mice (Fig. 1D) .
To examine whether hepatocytes expressed LCN2, hepatocytes were isolated and subjected to quantitative RT-PCR and western blot analyses. Lcn2 mRNA levels in hepatocytes were up-regulated by >200-fold in LPStreated mice compared to control mice (Fig. 1D ). LCN2 protein expression was detected at low levels in these isolated hepatocytes with the peak effect occurring 12 hours post-LPS injection (Supporting Fig. S2C ).
The above data revealed that Lcn2 mRNA levels were highly elevated but LCN2 protein levels were detected at low levels in hepatocytes, while high LCN2 protein levels were detected in neutrophils post-LPS injection, suggesting that LCN2 protein is rapidly secreted from hepatocytes but is stored in neutrophils.
To confirm this observation, we generated Lcn2
Hep2/2 mice and Lcn2
Mye2/2 mice. Serum LCN2 protein levels were significantly elevated in WT mice post-LPS injection (6 lg/mL) (Fig. 1E ). Compared to WT mice, Lcn2
Hep2/2 mice had significantly lower serum levels of LCN2 protein (1 lg/mL). There was a trend toward a decrease in serum LCN2 levels in Lcn2
Mye2/2 mice when compared with WT mice, but it did not reach statistical difference (Fig. 1E ). Serum alanine aminotransferase (ALT) levels were comparable among these three groups (Fig. 1E ).
DELETION OF THE Lcn2 GENE IN HEPATOCYTES OR IN MYELOID CELLS HAS MINIMAL EFFECT ON LPS-INDUCED INFLAMMATION
LCN2 was reported to play a role in inducing neutrophil infiltration and inflammation, (7, 26) but this notion was not confirmed by other studies. (15) To further clarify the role of LCN2 in neutrophil and macrophage recruitment and inflammation, we examined hepatic MPO 1 neutrophils, F4/80 1 macrophages and cytokines, and serum cytokines in WT, Lcn2 Hep2/2 mice. Quantitative RT-PCR and flow-cytometric analyses also confirmed that hepatic expression of the neutrophil marker Ly6g and intrahepatic cluster of differentiation 11b-positive/ granulocyte receptor 1-positive (CD11b 1 Gr1
1
) neutrophil numbers were comparable among all three groups (Supporting Fig. S3A ). In addition, we measured expression of CD62 ligand (CD62L) levels, a marker of neutrophil activation (down-regulation of CD62L represents neutrophil activation). Intrahepatic CD11b
CD62L
1 neutrophil numbers were , and Lcn2 mye2/2 mice were injected with LPS (1 mg/kg) for 6 hours, and serum LCN2 protein and ALT levels were measured (E). Liver tissues were subjected to immunohistochemistry with anti-LCN2, anti-MPO, or anti-F4/80 antibody. LCN2-positive, MPO-positive, and F4/80-positive cells per field were quantified (F). Representative images are shown in (B), (C), and (F). Values represent means 6 SEM (n 5 4-8). *P < 0.05, **P < 0.01, ***P < 0.001. Abbreviation: DAPI, 4 0 ,6-diamidino-2-phenylindole.
comparable among WT, Lcn2 Hep2/2 , and Lcn2
Mye2/2 mice treated with LPS, suggesting that LCN2 does not affect neutrophil activation and that the decreased serum LCN2 level in LPS-treated Lcn2 Hep2/2 mice is not due to the reduction of neutrophil activation (Supporting Fig. S3A) . Moreover, the number and percentage of circulating neutrophils, the number of nuclear factor jB p65 1 cells in the liver, serum levels of several cytokines, and hepatic expression of F4/80, tumor necrosis factor-alpha (Tnfa), and interleukin-6 (Il-6) mRNAs in all three groups were comparable (Supporting Fig. S3B-E) . Finally, in vitro experiments revealed that LPS treatment induced similar expression levels of mRNAs and proteins of several cytokines in neutrophils from WT and Lcn2 KO mice (Supporting Fig.  S4A,B) .
HEPATOCYTES AND MYELOID CELLS COOPERATIVELY FIGHT AGAINST SYSTEMIC BACTERIAL INFECTION THROUGH LCN2
To test the role of myeloid cell-derived and hepatocyte-derived LCN2 in the control of bacterial infection, we generated four lines of mice to test the mortality postinfection of K. pneumoniae: Lcn2
Hep2/2 , Lcn2 Mye2/2 , and Lcn2
DKO
. Both Lcn2
Hep2/2 and Lcn2 DKO mice began to die at around 12 hours, and all were dead within 36 hours after injection of a high dose (5 3 10 4 CFU) of K. pneumoniae ( Fig. 2A) . On the other hand, many WT and Lcn2
Mye2/2 mice survived until 40 hours ( Fig. 2A) . Next, we injected mice with a lower dose (5 3 10 3 CFU) of K. pneumoniae and sacrificed them 24 hours postinfection. Serum ALT, aspartate aminotransferase, and alkaline phosphatase levels were not different among these four groups (Fig. 2B) . Serum LCN2 levels were elevated (2.5 lg/mL) in Lcn2 f/f mice, but such elevation was significantly reduced in Lcn2
Hep2/2 and Lcn2 DKO mice (Fig. 2C ). There was a trend toward a reduction in serum LCN2 protein levels in Lcn2
Mye2/2 mice compared with Lcn2 f/f mice, but it did not reach statistical difference (Fig. 2C ). In agreement with levels of LCN2 protein, the bacterial burden in peripheral blood and the liver was higher in Lcn2
Hep2/2 and Lcn2 DKO mice but comparable in Lcn2 Mye2/2 mice when compared with WT Lcn2 f/f mice (Fig. 2C ). In addition, peritoneal lavage fluid LCN2 levels were elevated (2.8 lg/mL) in Lcn2 f/f mice and significantly reduced in the other three groups (Fig. 2D ). There was a trend toward a reduction in peritoneal lavage fluid LCN2 protein levels in Lcn2 DKO mice compared with Lcn2
Hep2/2 and Lcn2 Mye2/2 mice, but it did not reach statistical difference (Fig. 2D) . Bacterial burden in peritoneal lavage fluid was significantly higher in all three lines of mutant mice than that in WT Lcn2 f/f mice, which is consistent with LCN2 protein levels (Fig. 2D ).
LCN2 IS EXPRESSED IN NEUTROPHILS INTRACELLULARLY AND SECRETED BY HEPATOCYTES POST-BACTERIAL INFECTION
Injection of K. pneumoniae intraperitoneally caused similar levels of liver necrosis among Lcn2
, and Lcn2 DKO mice (Fig. 3A) . Immunohistochemical analyses revealed that LCN2 proteins were detected strongly in neutrophils in necrotic areas and weakly in hepatocytes in Lcn2 f/f mice. Interestingly, LCN2 was mainly detected in neutrophils in the necrotic area in Lcn2
Hep2/2 mice, while only weakly diffused LCN2 staining was detected in hepatocytes from Lcn2
Mye2/2 mice. No LCN2 protein staining was detected in Lcn2 DKO mice. Furthermore, greater K. pneumoniae staining per necrotic area was found in Lcn2 DKO mice compared to the other three groups (Fig. 3A,B) . There was a trend toward an elevation in the density of K. pneumoniae staining in Lcn2
Hep2/2 and Lcn2 Mye2/2 mice when compared to Lcn2 f/f mice, but it did not reach statistical difference (Fig. 3A,B) .
There was a large number of neutrophils recruited into the necrotic area in the liver post-K. pneumoniae infection, but there were no differences in neutrophil numbers per necrotic area among all four groups (Fig.  3A,B) . F4/80 staining was also performed to examine macrophages. Strong F4/80 1 macrophage staining was detected in non-necrotic areas in the liver tissues from K. pneumoniae-treated mice (Supporting Fig. S5A ). Interestingly, F4/80 staining was not detected in necrotic areas. Lack of F4/80 staining in necrotic areas may be due to macrophage death or down-regulation of F4/80 markers in macrophages. The number of macrophages in non-necrotic areas was comparable among Lcn2 f/f , Lcn2
Hep2/2
, and Lcn2 Mye2/2 mice. In addition, hepatic expression of F4/80, Il-6, and Tnfa mRNAs and of toll-like receptor 4 and p65 nuclear factor jB proteins was similar among these three groups post-K. pneumoniae infection (Supporting Fig.  S5B ).
MYELOID CELLS FIGHT AGAINST LOCAL LUNG BACTERIAL INFECTION THROUGH THE PRODUCTION OF LCN2
Next, we tested the role of hepatocyte LCN2 and myeloid LCN2 in a model of local lung bacterial infection induced by intratracheal intubation of K. pneumoniae (5 3 10 6 CFU). Bronchoalveolar lavage fluid LCN2 levels were significantly elevated (6 lg/ mL) in Lcn2 f/f mice postinfection, and such elevation was markedly reduced in Lcn2
Mye2/2 and Lcn2 DKO mice (<2.5 lg/mL) but not in Lcn2 Hep2/2 mice (left panel, Fig. 4A ). In addition, serum LCN2 levels were 3 CFU) of K. pneumoniae and sacrificed after 24 hours. Serum ALT, aspartate aminotransferase, alkaline phosphatase, and LCN2 levels were measured. Blood and liver samples were collected for bacterial CFU measurement. Peritoneal lavage fluid samples were collected for LCN2 protein measurement or for CFU measurement. Viable bacteria were determined by colony counts as total CFU per milliliter of blood/peritoneal lavage fluid. Values represent means 6 SEM. *P < 0.05, **P < 0.01, ***P < 0.001. Abbreviations: ALP, alkaline phosphatase; AST, aspartate aminotransferase; K.p, K. pneumoniae. markedly elevated (6 lg/mL) in Lcn2 f/f mice, and such elevation was markedly reduced in the other three groups (right panel, Fig. 4A ). There was a tendency of higher serum LCN levels in Lcn2
Mye2/2 compared to Lcn2
Hep2/2 and Lcn2 DKO mice, but it did not reach statistical difference (right panel, Fig. 4A ). Next, we measured bacterial load in bronchoalveolar lavage fluid and blood. Compared to Lcn2 f/f mice, Lcn2 Hep2/2 mice had comparable levels of bacterial burden in bronchoalveolar lavage fluid, while Lcn2
Mye2/2 and Lcn2 DKO mice had higher levels of bacterial burden (Fig. 4B) . In addition, in this intratracheal intubation model, blood bacterial load levels were 10 times lower than those in bronchoalveolar lavage fluid (Fig. 4B) . These blood bacterial burden levels were comparable among Lcn2
Mye2/2 , and Lcn2 f/f mice, whereas Lcn2 DKO mice had higher levels when compared to Lcn2 f/f mice (Fig. 4B ). Immunohistochemical analyses revealed that LCN2 levels were highly expressed in lung tissue from Lcn2 f/f and Lcn2
Hep2/2 mice after bacterial infection and that such expression levels were markedly reduced in Lcn2
Mye2/2 and Lcn2 DKO mice (Fig. 4C) , which is in agreement with LCN2 levels in bronchoalveolar lavage fluid (Fig. 4A) . Immunohistochemical analyses demonstrated that a similar number of MPO 1 neutrophils was recruited into the lungs in all four groups postinfection (Fig. 4C) . Quantitative RT-PCR analyses revealed that expression of Ly6g, Il-6, and Tnfa mRNA was highly up-regulated in the lungs from K. pneumoniae bacteria-infected mice compared to salinetreated control mice (Fig. 4D) . Expression of these inflammatory mediators was similar among these four groups except that Tnfa expression was lower in Lcn2
Hep2/2 mice than in Lcn2 f/f mice postinfection (Fig. 4E) .
Staining with F4/80 and ionized calcium binding adapter molecule 1 (IBA-1) was also performed to examine macrophages. Little F4/80 1 macrophage staining was detected in the lung tissues from K. pneumoniae-treated mice, but a large number of IBA-1 1 macrophages was detected (Supporting Fig. S6 ). These results suggest that infiltrating macrophages in the lungs express low levels of F4/80 but high levels of IBA-1. The number of IBA-1 1 macrophages in the lung was comparable among Lcn2 f/f , Lcn2
, and Lcn2
Mye2/2 mice, suggesting that LCN2 does not affect lung macrophage infiltration in this local bacterial infection model.
INTRACELLULAR, BUT NOT EXTRACELLULAR, LCN2 IS A COMPONENT OF NETs
NETs play an important role in the antibacterial infection by neutrophils. (16, 27) Thus, we tested whether LCN2 is also a component of murine NETs and contributes to NET formation. Mouse neutrophils were isolated from bone marrow and stimulated with phorbol 12-myristate 13-acetate (PMA) or calcium ionophore A23187, two well-known stimulators for NET formation in neutrophils, (16) to study NETs in vitro. The gold standard for NET quantification is to costain with a nuclear marker (e.g., DNA, cit-histone) and a neutrophil granule marker (e.g., MPO, elastase, LCN2/NGAL). (28) LCN2 is colocalized with cithistone in the NET structure, indicating that LCN2 is a component of mouse NETs (Fig. 5A,B) . However, LCN2 staining was not detected in all NETs, and only approximately 30% of mouse NETs had LCN2 staining (Fig. 5C) .
As expected, LCN2 was not detected in NETs in PMA-stimulated LCN2 KO neutrophils (Fig. 5C) . We then asked whether extracellular LCN2 can integrate into NETs. To test this hypothesis, we added recombinant LCN2 protein or culture medium from LPS-treated hepatocytes (containing LCN2) into PMA-stimulated LCN2 KO neutrophils. No positive LCN2 staining was detected in NETs from PMAstimulated LCN2 KO neutrophils ( Fig. 5C ; Supporting Fig. S7 ), suggesting that extracellular LCN2 from hepatocytes or other sources does not integrate into NETs and that the source of LCN2 in NETs is intracellular neutrophil granules.
LCN2 IS NOT REQUIRED FOR NET FORMATION IN VITRO AND IN VIVO
To test whether LCN2 is required for NET formation, we isolated neutrophils from WT and Lcn2 KO mice and stimulated them with PMA or cocultured them with K. pneumoniae. The degree of NETosis, as detected by cit-histone immunostaining, was comparable in WT and Lcn2 KO neutrophils stimulated with PMA (Fig. 6A,B) or K. pneumoniae (Supporting Fig.  S8 ), suggesting that intracellular LCN2 in neutrophils is not required for NET formation in isolated neutrophils. To determine whether extracellular LCN2 regulates NETosis, Lcn2 KO neutrophils were incubated with recombinant LCN2 protein and subsequently stimulated with PMA or K. pneumoniae. Incubation with recombinant LCN2 did not affect NETosis in Lcn2 KO neutrophils in vitro (Fig. 6A,B; Supporting  Fig. S8) .
Next, we investigated whether LCN2 is required for NET formation in vivo in mice infected with K. pneumoniae. Immunofluorescence microscopy revealed costaining of MPO and cit-histone in the liver samples (Fig. 6C) , suggesting that intrahepatic neutrophils developed NETs post-K. pneumoniae infection. However, there were no differences in NET formation among Lcn2 f/f , Lcn2
Mye2/2
, and Lcn2 DKO mice (Fig. 6C,D) . Furthermore, we quantified NET formation in serum and peritoneal lavage fluid by an enzyme-linked immunosorbent assay (ELISA)-based cit-histone-DNA binding test. In Lcn2 f/f WT mice, K. pneumoniae infection caused 3-fold and 1.8-fold increases in NET products in serum and peritoneal lavage fluid compared to a phosphate-buffered salinetreated control group, respectively. Similar elevation of NET products in serum and peritoneal lavage fluid was also observed in Lcn2
Hep2/2 , Lcn2 Mye2/2 , and Lcn2 DKO mice (Fig. 6E) . Overall, these results indicate that, in contrast to other neutrophil granule proteins, LCN2 is not required for NET formation in mice.
LCN2 CONTRIBUTES TO THE ANTIBACTERIAL FUNCTIONS OF NETs IN AN IRON-DEPENDENT MANNER
It is well documented that circulating LCN2 plays an important role in suppressing bacterial growth. (1) We asked whether LCN2 affects neutrophil phagocytosis and degranulation, which both are important for neutrophils to attack bacterial infection. Levels of neutrophil phagocytosis were comparable in the neutrophils from Lcn2 f/f , Lcn2
, and Lcn2 DKO mice; and the levels of degranulation were also comparable in the neutrophils from WT and Lcn2 KO mice (Supporting Fig. S9A,B) . These data suggest that LCN2 does not affect neutrophil phagocytosis and degranulation. Next we wondered whether the antibacterial functions of LCN2 is mediated through the NETs. To answer this question, the ability of NETs to kill bacteria was assessed in vitro. Incubation with NETs markedly inhibited bacterial growth in iron-free culture medium, and NETs from WT and Lcn2 KO mice had the same degree of inhibition against K. pneumoniae growth in vitro (Fig. 7A) . Because LCN2 inhibits bacterial infection by sequestering iron-containing siderophores, (4) we performed NET-mediated bacterial killing in iron-containing medium. Adding ferric iron markedly reduced the antibacterial functions of NETs and increased bacterial growth in a dose-dependent manner (Fig. 7B) . In the absence of iron (0 lM) or at high doses of iron (10 and 100 lM), there were no differences in bacterial growth from the incubation with NETs of WT and Lcn2 KO neutrophils. However, at low doses of iron (0.1 and 1 lM), bacterial growth from the incubation with Lcn2 KO NETs was greater compared to that from WT NETs. These results suggest that LCN2 present in NETs has antibacterial properties.
NGAL/LCN2 IS A COMPONENT OF HUMAN NETs THAT INFILTRATE HEPATIC TISSUE IN LIVER DISEASES
Healthy human blood neutrophils were isolated, stimulated with PMA, and subjected to immunofluorescent staining. NGAL (human ortholog of mouse LCN2) colocalized with elastase in the majority of neutrophil NETs, confirming that NGAL is a component of NETs from human neutrophils (Fig. 8A) . (21) Interestingly, almost all elastase 1 NETs were stained with NGAL (Fig. 8A) . Furthermore, immunofluorescent staining was also performed in liver samples from patients with various types of liver diseases. Colocalization of intracellular NGAL and cit-histone was frequently observed in liver samples from patients with SAH (Fig. 8B) ; cirrhotic liver tissues from HCV, NASH, and AH; and liver tissues from APAPinduced acute liver failure (Supporting Fig. S10) , with FIG. 7 . LCN2 contributes to NET-associated bacterial killing in an iron-dependent manner. (A) Bone marrow neutrophils from WT and Lcn2 KO mice were stimulated with A23187 to induce NETs (NET group) or without A23187 (control). NETs were isolated and then incubated with K. pneumoniae in an ironfree medium for 16 hours. Bacterial growth was determined by counting CFU. (B) NETs from WT or Lcn2 KO mice were incubated with K. pneumoniae in the presence of different concentrations of FeCl 3 for 16 hours. Bacterial growth was determined by counting CFU. Values represent means 6 SEM from three independent experiments. *P < 0.05, **P < 0.01. the highest number in SAH (Fig. 8C) . These results suggest that NGAL containing NETs frequently infiltrate into the liver in a variety of liver diseases.
Discussion
Several interesting findings are presented in the current study. First, hepatocytes and myeloid cells cooperatively control bacterial infection through the production of LCN2. Second, hepatocytes play a more important role in controlling systemic bacterial infection, while myeloid cells are more vital to combat local lung infection by generating LCN2. Third, we demonstrated that hepatocyte LCN2 does not bind to NETs but that neutrophils are the source of LCN2 present in NETs. Fourth, while LCN2 is not required for NET formation, it contributes to the bacteriostatic functions of NETs. Finally, NGAL/LCN2 containing NETs are detected in various types of liver diseases. LCN2 is reported to be induced under numerous pathological conditions in many organs such as liver, kidneys, lungs, bone, and brain. (2, 3) For example, LCN2 was found to be highly elevated in the serum and various types of fluids and tissues in mouse models and patients with liver disease. (3) However, which cell types are responsible for such high elevation remains unclear. In the current study, we demonstrated that after LPS injection both hepatocytes and intrahepatic neutrophils expressed Lcn2 mRNA but that LCN2 protein was mainly detected in neutrophils by immunohistochemical analysis. Genetic deletion of the Lcn2 gene in myeloid cells abolished LCN2 protein expression in intrahepatic neutrophils from LPS-treated mice but only slightly (no statistical difference) reduced serum LCN2 protein levels. In contrast, genetic deletion of the Lcn2 gene in hepatocytes did not affect LCN2 protein expression in intrahepatic neutrophils but markedly reduced serum levels of LCN2 protein.
Collectively, after LPS injection, LCN2 protein is highly up-regulated in hepatocytes and subsequently secreted into the circulation, which contributes to elevation of serum LCN2 protein. LCN2/NGAL protein contains a signal peptide that promotes its secretion, (29) which contributes to its secretion in hepatocytes. In contrast, LCN2/NGAL in neutrophils is stored in the specific granules, so neutrophils can carry LCN2/NGAL to the local infection area. (27) Similar to LPS induction of LCN2, infection with K. pneumoniae also elevates LCN2 protein with secreted form in hepatocytes and with intracellular form in neutrophils. Through generation of these different forms of LCN2, hepatocytes and neutrophils differentially combat systemic and local bacterial infection. Genetic deletion of the Lcn2 gene in hepatocytes (Lcn2 Hep2/2 ) reduced circulating LCN2 levels and increased bacterial loads in the blood post-systemic K. pneumoniae infection (through intraperitoneal injection) but did not affect LCN2 levels and bacterial loads in bronchoalveolar lavage fluid in a model of local lung infection induced by intratracheal intubation of K. pneumoniae. In contrast, genetic deletion of the Lcn2 gene in myeloid cells (Lcn2
) markedly reduced LCN2 levels and increased bacterial loads in bronchoalveolar lavage fluid in this intratracheal intubation lung infection model but did not affect LCN2 and bacterial loads in the systemic K. pneumoniae infection model. Our data suggest that secretion of LCN2 protein by hepatocytes plays an important role in systemic bacterial infection while neutrophils carry LCN2 protein in specific granules to combat local bacterial infection in the lungs. Interestingly, LCN2 protein from both hepatocytes and myeloid cells seems to be important to combat bacterial infection in the peritoneal cavity and necrotic area in the liver to limit bacterial growth after intraperitoneal injection of K. pneumoniae, which is probably because LCN2 protein from both cell types can reach the peritoneal cavity and liver necrotic area.
It was reported that LCN2 played a role in recruiting neutrophils. (26) However, in another study, it was suggested that the absence of LCN2 in neutrophils did not affect their ability to accumulate at the site of infection. (15) In our study, we found that global or cellspecific deletion of the Lcn2 gene affected neither circulating neutrophils nor the infiltrating neutrophils in the liver and lungs in both models of intraperitoneal injection and intratracheal intubation of K. pneumoniae infection as well as in the LPS injection model, suggesting that circulating LCN2 or intracellular LCN2 in neutrophils does not affect neutrophil recruitment and activation in the models we tested. In addition, hepatic and serum levels of several proinflammatory cytokines were equal among WT and three lines of Lcn2 conditional KO mice as demonstrated in the current report. In vitro treatment with recombinant LCN2 protein did not up-regulate expression of several cytokines (IL-6, IL-10, monocyte chemotactic protein-1, TNFa, and interferon-c) in both neutrophils and hepatocytes (data not shown). Collectively, our data suggest that LCN2 plays a minor role in regulating inflammation in several models we tested in our studies.
Formation of NETs is a recently identified mechanism to immobilize and kill bacteria by neutrophils. (16) NETs contain several neutrophil granule proteins such as neutrophil elastase and MPO. (30) LCN2 was identified in purified NETs from zymographic analyses of gelatinase (23) and from proteomic analyses. (21) Through immunohistochemical analyses, we visualized LCN2 protein in the NETs from activated mouse neutrophils and NGAL protein from activated human neutrophils in vitro and in vivo, indicating that LCN2/NGAL is a component of NETs in mice and humans. Interestingly, LCN2 protein was detected in only approximately 30% of NETs in mouse neutrophils, whereas most human NET samples contained NGAL. Thus, NGAL could be used as a marker of human NETs. Neutrophil granule proteins such as neutrophil elastase and MPO were reported to contribute to the formation of NETs, (30) although some studies do not support this notion. (31) In the present study, we demonstrated that genetic deletion of the Lcn2 gene in myeloid cells or hepatocytes did not affect the levels of NETs in the liver and serum from K. pneumoniae-infected mice. Neutrophils from Lcn2 2/2 mice generated the same number of NETs in vitro as those from WT mice after incubation with PMA or K. pneumoniae. However, while not required for NET formation, the NETs from Lcn2 2/2 neutrophils had reduced bacteriostatic activity in the presence of iron compared to those from WT neutrophils. Thus, the data from our studies suggest that LCN2 is not required for NET formation but contributes to the antibacterial function of NETs in an iron-dependent manner. NETs without LCN2 have a strong ability to inhibit/kill bacteria in an iron-independent manner; thus, LCN2 is incorporated into NETs as a byproduct following bacterial infection and does not play a role in the control of bacterial infection when local iron is absent. However, when local iron levels are elevated, LCN2 in the NETs likely enhances the bacteriostatic functions of NETs.
Finally, NGAL NETs were detected in the liver samples from various types of liver diseases. Given the well-documented bacteriostatic functions of LCN2, these NGAL NETs, together with circulating LCN2 protein, likely play an important role in host defense against bacterial infection in liver disease, especially in end-stage liver disease, which is often associated with bacterial infection. However, whether and how LCN2 regulates inflammation during bacterial infection and during chronic sterile inflammation in liver disease remain obscure. As mentioned in the introduction, the role of LCN2 in regulating inflammation has been controversial in various types of diseases, including liver disorders. (3) In the acute bacterial infection model used in the current study, genetic deletion of the Lcn2 gene in hepatocytes or myeloid cells, or both, had little impact on inflammatory responses, suggesting that LCN2 may not have an important role in regulating inflammation in acute bacterial infection; however, we cannot rule out that LCN2 may play a role in the control of inflammatory response during chronic bacterial infection. Furthermore, it was reported that LCN2 either promoted liver injury and inflammation (5) (6) (7) or protected against acute liver injury (1, 8) in various liver injury models with sterile inflammation. Thus, the role of LCN2 in the control of sterile inflammation requires further study to clarify.
